MOLECULAR SIGNATURES OF LUNG CANCER BASED ON GENE EXPRESSION RANKING OF RNA-SEQ DATA by Bondarenko, V. & Emmert-Streib, Frank
МЕДИЧНА ІНФОРМАТИКА 
ТА ІНЖЕНЕРІЯ 
ТЕЗИ ІІ-го з ' їзду з МІЖНАРОДНОЮ УЧАСТЮ 
«Медична та біологічна інформатика і кібернетика» 
УДК 616.24-006.6:577.21/.23:007:002.6:681.31 
МОЛЕКУЛЯРНІ СИГНАТУРИ РАКУ ЛЕГЕНІВ ЗА ДАНИМИ СЕКВЕНУВАННЯ 
РНК І РАНЖУВАННЯ ГЕНІВ ЗА РІВНЕМ ЕКСПРЕСІЇ 
В. Бондаренко, Ф. Еммерт-Стрейб1 
Інститут молекулярної біології і генетики НАН України 
Університет Технологій Тампере 
Гени, що належать до таких біолог ічних процесів як «кл ітинна міграція», «морфогенез епітелію», «розвиток крово-
носних судин» та «в ідпов ідь на реактивні форми кисню», забезпечують найточн ішу класифікац ію пухлинних зразків 
та зразків здорової тканини легенів. Ми припускаємо, що ранжування генів за рівнем їх експресі ї в якості основи 
для досл іджень транкриптому сприяє глибшому розумінню змін в транскриптом і клітини, що викликані кл ітинним 
переродженням. 
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Introduction. Whole Transcriptome Shotgun Se-
quencing or RNA-Seq is an experimental methodology 
which allows quantification of all transcripts expressed 
in a population of cells. In biomedicine, it is gradu-
ally gaining popularity to become a prevalent method 
for transcriptome analysis. Sequencing of individual 
human transcriptomes has become a powerful tool in 
disease biomarkers discovery and setting up individual 
treatment therapy of cancer and other disorders. 
Among all cancer-related diseases, lung cancer 
remains to be the leading cause of the majority of 
deaths worldwide. Because of diagnostic difficulties 
and high level of recurrence even after surgical treat-
ment, many efforts have been made to identify genes 
with prognostic properties. In several studies, on the 
basis of microarray gene expression data, diagnostic 
and prognostic gene expression signatures have been 
identified for non-small cell lung cancer. Interestingly, 
there is almost no overlap between some of the pub-
lished signatures i.e. the evidence indicates that none 
of the reported gene expression signatures are ready 
for clinical application. 
Methods. We explored a large-scale RNA-seq data-
set from a biomedical study of lung adenocarcinoma 
(84 patients). First, we investigated influence of the 
technical variation in the sequencing depth on the gene 
expression ranks using repetitive data subsampling and 
statistics, such as rank correlation, median and maxi-
mum rank changes. Secondly, using gene expression 
ranks, we applied a Bayesian classifier as a diagnostic 
predictor for lung cancer. As a feature selection mecha-
nism, we used prior biological information from the 
Gene Ontology (GO) project database. 
Results and conclusions. On the basis of the gene 
expression rank changes between normal and cancer 
samples, we provide an accurate classification of 
cancer and non-cancer samples. We demonstrate, that 
genes belonging to processes of »cell migration», 
»epithelium morphogenesis», »blood vessels devel-
opment» and »response to oxygen levels» result in 
best performance of the lung cancer and non-cancer 
transcriptomes classification. We suggest that our re-
sults are beneficial in terms of using gene expression 
ranking as a basis for whole-transcriptome studies and 
provide novel insights in our understanding of the tran-
scriptome disruptions caused by cancer progression. 
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